Check the latest share price of Nectar Lifescience Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
₹24.28
▲0.08%
as on 10:24AM, 04 Jun 2025
NSE
Get live Nectar Lifescience Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 10.62 % |
3 Month Return | -7.48 % |
1 Year Return | -16.63 % |
3 Year Return | -4.11 % |
5 Year Return | + 69.06 % |
Market Stats | |
Previous Close | ₹24.26 |
Open | ₹24.27 |
Volume | 1.68L |
Upper Circuit | ₹26.68 |
Lower Circuit | ₹21.83 |
Check Nectar Lifescience Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹544.06 Cr
Return on Equity (ROE)
0.47
PE Ratio (TTM)
31.92
Return on capital employed (ROCE)
5.96
Industry PE ratio
55.92
Beta (LTM)
0.9
P/B Ratio
0.63
Dividend Yield
0PEG Ratio
79.8
Quarterly Earnings Growth YOY
399.36
EPS (TTM)
0.22
Sector
Pharmaceuticals
Book Value
47.68
Technical Analysis
Bearish
View Technical Analysis
Investing in Nectar Lifescience Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Nectar Lifescience Ltd or NECLIFE on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Nectar Lifescience Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Nectar Lifescience Ltd with just a few clicks!
Track how Nectar Lifescience Ltd P/E has moved over time to understand its valuation trends.
Nectar Lifescience Ltd in the last 5 years
Lowest (-284.58x)
December 21, 2023
Today (31.92x)
June 3, 2025
Industry (55.92x)
June 3, 2025
Highest (403.33x)
August 26, 2020
Today’s Price to Earnings Ratio: 31.92x
Get the annual and quarterly financial summary of Nectar Lifescience Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Nectar Lifescience Ltd.
Nectar Lifescience Ltd’s net profit jumped 399.36% since last year same period to ₹7.84Cr in the Q3 2024-2025. On a quarterly growth basis, Nectar Lifescience Ltd has generated 40% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 - translating a dividend yield of 0.21%.
Read More about DividendsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Nectar Lifescience Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 44.53% | 0.00 | |
Foreign Institutions | 1.65% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 53.65% | 0.00 | |
Others | 0.18% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Nectar Lifescience Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 544.06 | 13.81% | 0.69 | NA | NA | |
NA | 66.11 | 99.2% | 0.53 | NA | NA | |
NA | 928.53 | 111.94% | 0.53 | NA | NA | |
NA | 27.06 | 25.78% | 0.50 | NA | NA | |
NA | 970.83 | 276.25% | 0.91 | NA | NA |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 359.85 Cr → 455.56 Cr (in ₹), with an average increase of 11.0% per quarter
Profit Spike
Netprofit is up for the last 4 quarters, 0.59 Cr → 7.84 Cr (in ₹), with an average increase of 51.9% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 0.73% to 1.65% in Mar 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.53% of holdings in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.0% return, outperforming this stock by 127.3%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.3% return, outperforming this stock by 74.0%
Retail Holding Down
Retail Investor have decreased holdings from 54.72% to 53.65% in Mar 2025 quarter
Price Dip
In the last 7 days, NECLIFE stock has moved down by -8.1%
Organisation | Nectar Lifescience Ltd |
Headquarters | Chandigarh |
Industry | Pharmaceuticals |
CEO | Sanjiv Goyal |
E-voting on shares | Click here to vote |
Nectar Lifescience Ltd share price today stands at ₹24.28, Open: ₹24.27, Previous Close: ₹24.26, High: ₹24.57, Low: ₹23.98, 52 Week High: ₹56.5, 52 Week Low: ₹20.02.
Today's traded volume of Nectar Lifescience Ltd is 1.68L. Which means that 1.68L shares of Nectar Lifescience Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Nectar Lifescience Ltd is ₹544.06 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Nectar Lifescience Ltd’s 52 week high is ₹56.5 and 52 week low is ₹20.02. The current share price of Nectar Lifescience Ltd is ₹24.28, which is -57.03% down from its 52 week high and 21.28% up from its 52 week low.